Food and Drug Administration:

Regulations Requiring Manufacturers To Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients

OGC-99-22: Published: Dec 21, 1998. Publicly Released: Dec 21, 1998.


Additional Materials:


Office of Public Affairs
(202) 512-4800

Pursuant to a legislative requirement, GAO reviewed the Food and Drug Administration's (FDA) new rule on requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. GAO noted that: (1) the final rule would require pediatric studies of certain new and marketed drugs and biological products; (2) it would also partially address the lack of pediatric use information by requiring that manufacturers of certain products provide sufficient data and information to support directions for pediatric use for the claimed indications; and (3) FDA complied with applicable requirements in promulgating the rule.

Oct 18, 2017

Oct 4, 2017

Oct 3, 2017

Sep 29, 2017

Sep 13, 2017

Sep 12, 2017

Sep 8, 2017

Sep 7, 2017

Looking for more? Browse all our products here